Reports for HYDROCHLOROTHIAZIDE

Ingredient

HYDROCHLOROTHIAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-06-16 2023-06-27 195124
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Actual shortage 2025-10-30 2026-01-22 270663
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Actual shortage 2025-10-30 2026-01-15 270666
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-06-16 2023-06-27 195204
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 12.5MG TABLET Resolved 2020-11-06 2021-02-05 128016
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-06-08 2023-06-27 194122
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-02-02 2023-02-16 183398
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 25MG TABLET Resolved 2021-01-07 2021-01-14 131090
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 25MG TABLET Resolved 2020-12-17 2020-12-18 130313
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 25MG TABLET Resolved 2020-10-30 2020-12-03 127625

Showing 651 to 660 of 756

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-02-26 2018-02-26 41047
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020
APO-CANDESARTAN/HCTZ 25MG 32MG TABLET Discontinued 2018-02-26 2018-05-03 41011
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769

Showing 21 to 30 of 116